Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy

Blood Pressure Monitoring

Volumn 4, Issue 5, 1999, Pages 263-266

  Waeber, Bernard ^a   Brunner, Hans R ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive therapy; Clinical trials; Placebo effect; Trough:peak ratio; Variability of blood pressure; White coat effect

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT;

ACCURACY; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; SHORT SURVEY; WHITE COAT HYPERTENSION;

EID: 0033511787     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-199900450-00009     Document Type: Short Survey

References (32)

1. 1 Pickering TG. A review of national guidelines on the clinical of ambulatory blood pressure monitoring. Blood Press Monit 1996; 1:151-156.
2. 2 Pickering TG. White-coat hypertension in a changing era of medical care. Blood Press Munit 1996; 1:27-32.
3. 3 Clement DL, De Buyzere M, Duprez D. Prognostic value of ambulatory blood pressure monitoring. J Hypertens 1994; 12:857-864.
4. 4 Zanchetti A, Bond MG, Henning M, Neiss A, Mancia G, Dal Palù C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 10:385-391.
5. 5 Imai Y, Ohkubo T, Tsuji I, Nagai K, Satoh H, Hisamichi S. et al. Prognostic value of ambulatory and home blood pressure measurements in comparison to screening blood pressure measurements: pilot study in Ohasama. Blood Press Monit 1996; 1:51-58.
6. 6 Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31:712-718.
7. 7 Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97:48-54.
8. 8 Waeber B, Burnier M, Perret F, Nussberger J, Brunner HR. Ambulatory blood pressure measurement and antihypertensive therapy. J Hypertens 1989; 7 (suppl):33-39.
9. 9 Coats JS. What blood pressure measurements should be used for the ideal clinical trial? Blood Press Monit 1996; 1 (suppl 2):41-44.
10. 10 White WB. Clinical relevance of ambulatory versus clinic blood pressure when evaluating antihypertensive therapy. Blood Press Monit 1996; 1 (suppl 2):170-173.
11. 11 Waeber B, Scherrer U, Petrillo A, Bidiville J, Nussberger J, Waeber G, et al. Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording. Lancet 1987; ii:732-734. Treatment of 34 hypertensive patients with uncontrolled hypertension despite antihypertensive therapy was adjusted with the aim of reducing office diastolic blood pressure to 90 mmHg or less within 3 months. At the outset of the study recorded ambulatory diastolic blood pressure was 90 mmHg or less for half of the patients and above 90 mmHg for the other half. Intensifying the therapy resulted in an additional decrease in ambulatory blood pressure only for patients with high ambulatory blood pressures at initial evaluation.
12. 12 Parati G, Ulian L, Santuciu C, Mancia G. Reproducibility of blood pressure measurement. Blood Press Monit 1996; 1:205-209.
13. 13 di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 1983; 5:264-269. This article is important because it shows the intervals at which intermittent blood pressure readings should be taken to provide a reliable estimate of the mean of continuous, beat-to-beat blood pressure measurements. The intervals between non-invasive ambulatory blood pressure readings should not exceed 30 min.
14. 14 Coats AJS, Radaclli A, Clark SJ, Conway JJ, Sleight O. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992; 10:385-391. This is key work on a methodological point of view. It shows how the statistical power of a clinical trial depends on the number of blood pressure measurements, which explains why ABPM is particularly useful in the assessment of antihypertensive efficacy in clinical trials
15. 15 Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Porcellati C. Nocturnal pressure is the true pressure. Blood Press Monit 1996; 1 (suppl 2):81-85.
16. 16 Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875-878.
17. 17 Fogari R, Zoppi A, Malamani GD, Lazzari P, Destro M, Corradi L. Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens 1993. 6:1-7.
18. 18 Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998; 16:733-738.
19. 19 Myers MG, Reevos RA, White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991; 4.-844-849.
20. 20 Waeber G, Beck G, Waeber B, Bidiville J, Nussberger J, Brunner HR. Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures. J Hypertens 1988; 6:239-245.
21. 21 Elijovich F, Laffer CL. Magnitude, reproducibility, and components of the pressor response to the clinic. Hypertension 1990; 15:1161-1165.
22. 22 Waeber B, Heynen G, Brunner HR. Analysis of ambulatory blood pressure monitoring: the problem of 'white-coat' hypertension, responders and non-responders. Blood Press Monit 1996; 1 (suppl 2):289-291.
23. 23 Weber MA. Whole-day blood pressure. Hypertension 1988; 11:288-298.
24. 24 Fagard R, Staessen J, Thijs L. Ambulatory blood pressure during antihypertensive therapy guided by conventional pressure. Blood Press Monit 1996; 1 (suppl 2):279-281.
25. 25 Lipicky RJ, Trough:peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994; 12 (suppl 8):17-18. The trough : peak ratio has become a classical index for characterizing the profile of the blood-pressure-lowering action of antihypertensive drugs. This paper describes for the first time the rationale behind this index.
26. 26 Staessen JA, Celis H, Ginocchio G, Thijs L, Van Hoff R, Wang J, et al. Measurement of the trough-peak ratio by ambulatory blood pressure monitoring. Blood Press Monit 1996; 1 (suppl 2):45-50.
27. 27 Meredith PA, Elliott L. Trough-peak ratios for antihypertensive agents: methodological considerations. Blood Press Monit 1996; 1 (suppl 2):293-297.
28. 28 Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Press Monit 1996; 1 (suppl 2):161-169.
29. 29 Omboni S, Parati G, Mancia G. The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment of hypertension. Blood Press Monit 1996; 1 (suppl. 2):201-204.
30. 30 Dupont AG, Van der Niepen P, Six RO. Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol 1987; 24:106-109.
31. 31 Staessen JA, Thijs L, Clement D, Davidson C, Fagard R, Lehtonen A, ef al. Ambulatory pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. J Hypertens 1994; 12:1035-1039. There is no doubt that placebo can lower blood pressure assessed conventionally in a clinical setting. Whether non-invasive ambulatory blood pressure is also lowered by placebo is still being debated. Results of this study concerning a large number of patients show that prolonged administration of placebo induces minimal changes in ambulatory blood pressure. This is a key item of information for the design and the interpretation of clinical trials.
32. 32 White WB, Walsh SJ. Ambulatory monitoring of the blood pressure in multicenter clinical trials. Blood Press Monit 1996; 1 (suppl. 2):227-229.